EKF Diagnostics Holdings plc (AIM:EKF)
London · Delayed Price · Currency is GBP · Price in GBX 27.00
+0.20 (0.75%)
Jun 19, 2026, 8:31 AM GMT
EKF Diagnostics Holdings Market Cap
EKF Diagnostics Holdings has a market cap or net worth of 115.37 million as of June 18, 2026. Its market cap has decreased by -4.85% in one year.
Market Cap
115.37M
Enterprise Value
104.30M
Revenue
51.56M
Ranking
n/a
PE Ratio
57.03
Stock Price
27.00
Market Cap Chart
Since June 30, 2003, EKF Diagnostics Holdings's market cap has increased from 2.27M to 115.37M, an increase of 4,974.72%. That is a compound annual growth rate of 18.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 115.37M | 0.70% |
| Dec 31, 2025 | 114.57M | -6.48% |
| Dec 31, 2024 | 122.51M | -14.69% |
| Dec 29, 2023 | 143.61M | -36.87% |
| Dec 30, 2022 | 227.47M | -34.63% |
| Dec 31, 2021 | 347.95M | 6.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 206.03B |
| GSK plc | 77.84B |
| Haleon | 29.53B |
| Smith & Nephew | 9.60B |
| Diaceutics | 120.66M |
| Bioventix | 90.13M |
| INSPECS Group | 85.91M |
| Faron Pharmaceuticals Oy | 85.21M |